1. Home
  2. Azioni
  3. Francia
  4. Euronext Paris
  5. Novacyt
  6. Notizie
  7. Pubblicazioni ufficiali
    ALNOV   FR0010397232

NOVACYT

(ALNOV)
  Rapporto
Tempo reale Euronext Paris  -  09:00 30/06/2022
1.804 EUR   -2.14%
28/06La francese Novacyt lancia il test sul vaiolo delle scimmie
MT
28/06Novacyt annuncia il lancio del suo test di reazione a catena della polimerasi per il vaiolo delle scimmie, di uso esclusivo per la ricerca, in risposta alla recente epidemia del virus nei Paesi non endemici.
CI
16/06Novacyt presenta una domanda riconvenzionale contro il Ministero della Salute e dell'Assistenza Sociale del Regno Unito
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietÓFinanzaRevisioniDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Pubblicazioni ufficiali
21/06/22Mixed general shareholder meeting 
21/06/22Mixed general shareholder meeting 
01/06/22Mixed general Shareholders meeting notice 
31/05/22Monthly statement on outstanding equity shares and voting rights 
13/05/22Mixed general Shareholders meeting 
30/04/22Monthly statement on outstanding equity shares and voting rights 
28/04/22Press Release 
28/04/22Annual results 
28/04/22Annual results 
28/04/22Management Report 
28/04/22Management Report 
31/03/22Monthly statement on outstanding equity shares and voting rights 
11/03/22Crossing thresholds 
11/03/22Crossing thresholds 
28/02/22Monthly statement on outstanding equity shares and voting rights 
18/02/22Crossing thresholds 
18/02/22Crossing thresholds 
31/01/22Monthly statement on outstanding equity shares and voting rights 
31/12/21Monthly statement on outstanding equity shares and voting rights 
30/11/21Monthly statement on outstanding equity shares and voting rights 
31/10/21Monthly statement on outstanding equity shares and voting rights 
18/10/21Press Release 
01/10/21Mixed general Shareholders meeting notice 
30/09/21Monthly statement on outstanding equity shares and voting rights 
29/09/21Infos Business 
29/09/21Infos Business 
27/09/21Half-year results 
27/09/21Half-year results 
27/09/21Half-year report 
27/09/21Half-year report 
10/09/21Mixed general Shareholders meeting notice 
31/08/21Monthly statement on outstanding equity shares and voting rights 
20/08/21Mixed general Shareholders meeting 
18/08/212nd quarter earnings 
22/06/21Annual results 
22/06/21Annual results 
22/06/21Auditors Report 
22/06/21Financial report 
01/06/21Monthly statement on outstanding equity shares and voting rights 
31/05/21Monthly statement on outstanding equity shares and voting rights 
09/04/21Infos Business 
29/01/214th quarter earnings 
29/01/214th quarter earnings 
26/01/21Crossing thresholds 
26/01/21Crossing thresholds 
13/01/21Crossing thresholds 
13/01/21Crossing thresholds 
31/12/20Monthly statement on outstanding equity shares and voting rights 
30/11/20Monthly statement on outstanding equity shares and voting rights 
31/10/20Monthly statement on outstanding equity shares and voting rights 
15/10/20Acquisition 
15/10/20Acquisition 
30/09/20Monthly statement on outstanding equity shares and voting rights 
17/09/20Half-year results 
17/09/20Half-year results 
16/09/20Nomination 
16/09/20Nomination 
31/08/20Monthly statement on outstanding equity shares and voting rights 
14/08/20Monthly statement on outstanding equity shares and voting rights 
14/08/20Monthly statement on outstanding equity shares and voting rights 
14/08/20Monthly statement on outstanding equity shares and voting rights 
14/08/20Monthly statement on outstanding equity shares and voting rights 
31/07/20Monthly statement on outstanding equity shares and voting rights 
13/07/202nd quarter earnings 
30/06/20Half-year report 
30/06/20Half-year report 
18/02/20Monthly statement on outstanding equity shares and voting rights 
Prossimo evento su NOVACYT